Related Articles
Transforming growth factor‑β, insulin‑like growth factor I/insulin‑like growth factor I receptor and vascular endothelial growth factor‑A: Prognostic and predictive markers in triple‑negative and non‑triple‑negative breast cancer
Association between transforming growth factor-β1 expression and the clinical features of triple negative breast cancer
Prognostic significance of CD117 expression and TP53 missense mutations in triple-negative breast cancer
Identification of dysregulated microRNAs associated with diagnosis and prognosis in triple‑negative breast cancer: An in silico study
Clinical characteristics and prognostic analysis of triple‑negative breast cancer patients